THE EFFECT of CHANGES in BODY SODIUM on EXTRACELLULAR FLUID VOLUME and ALDOSTERONE and SODIUM EXCRETION by NORMAL and EDEMATOUS MEN I by LEROY E

THE EFFECT of CHANGES in BODY SODIUM on EXTRACELLULAR FLUID VOLUME and ALDOSTERONE and SODIUM EXCRETION by NORMAL and EDEMATOUS MEN I by LEROY E

THE EFFECT OF CHANGES IN BODY SODIUM ON EXTRACELLULAR FLUID VOLUME AND ALDOSTERONE AND SODIUM EXCRETION BY NORMAL AND EDEMATOUS MEN I By LEROY E. DUNCAN, JR., GRANT W. LIDDLE, AND FREDERIC C. BARTTER WITH THE ASSISTANCE OF KATHERIN BUCK (From the Clinic of General Medicine and Experimental Therapeutics, National Heart Insti- tute, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare, Bethesda, Md.) (Submitted for publication April 6, 1956; accepted August 2, 1956) The presence of a sodium-retaining hormone, Sodium uptake is thus the percentage of the total ex- aldosterone, in the adrenal gland and adrenal ve- change capacity of the resin occupied by sodium. The uptake of potassium by resin was calculated in the same nous blood (1-4), the increased urinary excretion fashion on the assumption that there were 10 mEq. of of aldosterone during sodium depletion (5, 6) and potassium per day uncombined with resin in the stool. the inability of men and animals with adrenal in- The results are essentially the same if it is assumed sufficiency to conserve sodium support the con- that all of the sodium and potassium in the stool is com- cept that the process by which the sodium content bined with resin. Urinary extracts of aldosterone were prepared by the and thus the extracellular fluid (ECF) volume of following procedure within three days of the collection the body are regulated includes adrenocortical of urine. The urine was acidified to pH 1 with HCI and control of sodium excretion by aldosterone secre- divided into 1500 ml. batches. Water was added if tion (7). necessary to achieve the proper volume. Each batch of That aldosterone is involved in the formation of urine was then placed in a glass tube 120 cm. high by is an increased 4.3 cm. in diameter. Urine was pumped from the bot- edema indicated by urinary output tom of this tube to the bottom of another tube 120 cm. of this hormone by patients with edema caused by high by 2.5 cm. in diameter. It ascended in droplets at heart failure, portal cirrhosis or nephrosis (8-13). the rate of 10 ml. per minute through 350 ml. of dichloro- The present work further defines the role of methane to the top of the tube whence it was returned to aldosterone in the control of ECF volume of nor- the top of the first tube. This extraction was continued mal men and in the formation of edema for 22 hours. The dichloromethane had been previously by patients purified by passage through a column of silica gel. Fol- with heart failure or portal cirrhosis. lowing the extraction the dichloromethane was washed twice with 0.1 its volume of 0.1 N sodium carbonate and METHODS twice with 0.1 its volume of water. The washings were backwashed with their volume of dichloromethane. The The patients lived on a metabolic ward during the dichloromethane was then evaporated to dryness by pass- studies. Constant diets were prepared from uniform lots ing nitrogen through it under reduced pressure at room of food. The patients were weighed each morning after temperature. The residue was dissolved in ethanol and voiding and before breakfast. Blood samples were stored at -7° C. until it was assayed in dogs for aldo- drawn 3 times a week before breakfast. Total collec- sterone (15). Urinary 17-hydroxycorticoids were de- tions of urine and feces were made. Urine was kept at 5° termined in several patients by a modification of the C. during and following collection. Sodium and potas- method of Silber and Porter (16). sium in diets, urine, feces and sera, and cation exchange Venous pressure was measured by connecting a ma- resin in feces were determined as previously described nometer directly to a needle inserted in an antecubital (14). Uptake of sodium by resin was calculated on the vein. With the patient reclining the venous pressure was assumption that there were 2 mEq. of sodium per day recorded as the height of the fluid above a plane half- uncombined with resin in the stool (14). way between the uppermost portion of the sternum and the back of the patient. Uptake of sodium in per cent = mEq. fecal sodium/day - 2 100. mEq. fecal resin/day x PROCEDURE AND RESULTS Dietary sodium for the different subjects varied 1Parts of this work have been reported briefly in the from to 12 discussion of the paper of Dr. John A. Luetscher, Jr. at 6 mEq. per day. Dietary potassium the 1955 Laurentian Hormone Conference and in abstract was supplemented by potassium on cation ex- form (Circulation, 1955, 12, 697). change resin and in some cases by potassium salts. 1299 1300 LEROY E. DUNCAN, JR., GRANT W. LIDDLE, AND FREDERIC C. BARTTER 300, SODIUM 253 millimols of sodium chloride and 55 millimols INTAKE 350-I E of sodium lactate. This was infused in a MEO. / DAY period of (. a 2 hours or less. The excretion of 17-hydroxy- 761 WEIGHT corticoids, determined daily in several patients, K was normal and did not vary during the studies. URINARY ALDOSTERONE 30-Il Noruw subjects MCG. / DAY 300- Two normal subjects were studied. The re- URINARY sults of one study are shown in Figure 1. The SODIUM I 50- ME. / DAY results of the other study were essentially the O- - E SODIUM 301 same. Prior to the collection of data the subjects UPTAKE BY ESIN l: __, were depleted of sodium by resin and, a low sodium diet. They were studied while depleted of sodium, - L D. Ir , 1,, 1 , 19 AET. 1-1-,161'1 I-lgi9,1 14 19 then while receiving intravenous saline daily, and NORMALd' DAYS finally after being again depleted of sodium by FIG. 1. STUDY OF A NORMAL MAN resin and a low sodium diet. When each subject During days 1 through 16 and days 19 through 24 he was depleted of sodium, his weight, urinary excre- was depleted of sodium by cation exchange resin and a tion of sodium, and sodium uptake by resin were low sodium diet. During days 9 through 14 saline was lower and urinary excretion of aldosterone was given intravenously. Retention of enough sodium to pro- higher than when body sodium was greater be- duce a small expansion of extracellular fluid (ECF) volume as estimated from body weight led to a fall of cause of the daily intravenous infusion of saline. urinary aldosterone to a very low level and to a greatly The average urinary excretion of aldosterone by increased urinary excretion of sodium. During days 1 each of the normal subjects during the days when through 6 and days 19 through 24 the urinary sodium intravenous saline was administered was 6 mi- excretions were 0.6 and 0.7 mEq. per day. crograms per day. Average serum sodium con- centrations for the two subjects were slightly Each subject ingested daily 355 mEq. (43 gm.) of higher during the days that they received saline a carboxylic cation exchange resin 2 in the hydro- intravenously (Table I). During the days when gen and potassium form. The intake of resin be- saline was given intravenously, the uptake of po- gan some days before the collection of data. tassium by resin was lower and the urinary potas- Whenever intravenous saline was given, the sium higher than during the days when the sub- quantity given each day was 2 liters containing jects were depleted of sodium. Serum potassium concentrations 2 The preparation used was Natrinil, a pharmaceutical in both were slightly higher during grade of Amberlite IRC-50 suitably prepared for thera- the days that they received saline intravenously peutic use. (Table I). TABLE I Serum elcctrolyte concenrations * during sodium dePtiox and repltion Serum sodium Serum potassium Sodium sodium Sodium Sodium Subject Di nosis depleted repleted depleted repleted L. D. Normal 139 141 3.9 4.1 W. Y. Normal 139 140 4.4 4.5 F. H. Portal cirrhosis 140 144 4.5 4.2 W. G. Portal cirrhosis 140 145 3.0 3.6 .L. Arberioslerotic heart disease 138 144 4.5 4.6 W. B. Hypertensive heart disease 138 138 5.5 5.6 F. R. Hypetensive heart disease 141 142 4.4 5.0 C. G. Syphilitic aortic insufficiency 127 129 6.5 5.7 V. B. Arteriosclerotic heart disease 142 128 4.3 5.6 * These values are the averages of the results of the determinations made during the periods of depletion and re- pletion. EXTRACELLULAR FLUID VOLUME AND ALDOSTERONE 1301 Patients with cirrhosis VENOUS PRESSURE Two patients with portal cirrhosis were studied. MM. WATER Results from one study are shown in Figure 2. 560 - Those of the other study were essentially the same. WEIGHT D.uring the first part of the study neither patient KM had subcutaneous edema. One had slight ascites; 9S~~~~~~~~~ URINARY 95 the other had no ascites. Saline was then given ALDOSTERONE MCG/DAY intravenously'daily until subcutaneous edema and 0 marked ascites were present. The weight of each URINARY SODIUM patient increased 7 Kg. The daily. infusion of MEQ.JDAY saline was then discontinued, and the edema and 100 SODIUM 20- ascites allowed to persist'.for a number of days. UPTAKE For one of the patien'ts there was an additional BY RESIN period of study removal of the ascitic I IG I following W.B. 6I 1121 221 51 AET. MAN fluid by paracentesis. DAYS When edema and ascites were present, urinary H.C.V.D. excretion of sodium and sodium uptake by resin FIG. 3. STUDY OF A PATIENT WITH CONGESTIVE HEART excretion aldosterone FAILURE were higher and urinary of The excretion of sodium on resin resulted in a gradual was lower than when there, was''no edema and little loss of edema which was not detectable after day 12.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us